Skip to main content
. 2020 Apr 28;39:73. doi: 10.1186/s13046-020-01579-x

Fig. 1.

Fig. 1

CPI-613 induces the morphological changes of mitochondrial and inhibits cell viability in pancreatic cancer cells. a The effects of CPI-613 on mitochondrial morphology in AsPC-1 and PANC-1 cells determined by TEM. b, c The effects of CPI-613 on cell viability. b AsPC-1 and PANC-1 cells were treated with a dose range of CPI-613 for 48 h, followed by MTT assays. c AsPC-1 and PANC-1 cells were treated with or without 200 μM CPI-613 for 7 days, followed by crystal violet staining and quantification by a plate reader at OD570. d The effects of CPI-613 on 3D cell viability. AsPC-1 and PANC-1 cells growing in the SeedEZ scaffold were treated with or without 200 μM CPI-613 for 5 days, and cell viability was measured by Phalloidin staining (left) and alamarBlue (right), respectively. **p < 0.01